Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-01-2017 | Letter to the Editor

Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? – Wait for confirmation study

Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30

Authors: Regine Kluge, Lars Kurch, Thomas Georgi, Dirk Hasenclever

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2017

Excerpt

Dear Sir, …

Jorgov L, Montravers F, Balogova S, Ragu C, Pacquement H, Leblanc T, et al. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT. Eur J Nucl Med Mol Imaging. 2016;43:1220–30.

Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994;69(6):979–85.CrossRefPubMedPubMedCentral

Lausen B, Schumacher M. Evaluating the effect of optimized cutoff values in the assessment of prognostic factors. Computational Statistics & Data Analysis. 1996;21(3):307–26.CrossRef

Title: Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? – Wait for confirmation study
Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30
Authors: Regine Kluge
Lars Kurch
Thomas Georgi
Dirk Hasenclever
Publication date: 01-01-2017
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2017
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3534-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? – Wait for confirmation study

Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast

Reply to Rahbar K et al.

EANM Springer Prizes awarded at EANM’ 16 Barcelona

PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique

Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression

Erratum to: Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351